Carfilzomib, Free Base

Name Carfilzomib, Free Base
Supplier Biorbyt
Catalog orb153608
Prices $272.00, $315.00, $349.00, $391.00, $510.00, $740.00
Sizes 5 mg, 10 mg, 50 mg, 25 mg, 100 mg, 200 mg
Cas Number [868540-17-4]
Pubchem 11556711
Chemical Name (2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide
Formula C40H57N5O7
Molecular Weight 719.91 g/mol
Purity >99% pure
Description Carfilzomib, also known as PR-171, is an irreversible, epoxomicin-related proteasome inhibitor. Carfilzomib is a second-generation proteasome inhibitor that is being investigated as a potential treatment for patients with multiple myeloma and solid tumors. It is being studied in several clinical trials either as a single-agent or in combination with other therapies.
Supplier Page Shop

Product images